publications
Full publication list in reverse chronological order.
Selected
-
Plasma proteomic associations with genetics and health in the UK BiobankMeasured about 3,000 blood proteins in 54,000 UK Biobank participants and mapped more than 14,000 genetic variants that influence their levels, most of them previously unknown.Nature, 2023 -
Interpreting type 1 diabetes risk with genetics and single-cell epigenomicsCombined a genetic study of type 1 diabetes in more than 500,000 samples with single-cell maps of the pancreas and implicated exocrine pancreas cells, not just immune cells, in disease risk.Nature, 2021 -
Integrating genetics with single-cell multiomic measurements across disease states identifies mechanisms of beta cell dysfunction in type 2 diabetesIdentified two beta cell subtypes whose abundance shifts in type 2 diabetes and whose accessible chromatin is enriched for type 2 diabetes risk variants.Nature Genetics, 2023 -
Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes riskMapped chromatin accessibility in thousands of individual islet cells to show which cell types and cell states carry type 2 diabetes genetic risk.Nature Genetics, 2021
All publications
2026
- Genetic dose-response modelling predicts drug mechanisms, dosing, and adverse eventsmedRxiv, 2026Preprint DOI
2025
- Trans-eQTL mapping prioritises USP18 as a negative regulator of interferon response at a lupus risk locusNature Communications, 2025
2024
2023
-
Plasma proteomic associations with genetics and health in the UK BiobankMeasured about 3,000 blood proteins in 54,000 UK Biobank participants and mapped more than 14,000 genetic variants that influence their levels, most of them previously unknown.Nature, 2023 -
Integrating genetics with single-cell multiomic measurements across disease states identifies mechanisms of beta cell dysfunction in type 2 diabetesIdentified two beta cell subtypes whose abundance shifts in type 2 diabetes and whose accessible chromatin is enriched for type 2 diabetes risk variants.Nature Genetics, 2023
2022
2021
-
Interpreting type 1 diabetes risk with genetics and single-cell epigenomicsCombined a genetic study of type 1 diabetes in more than 500,000 samples with single-cell maps of the pancreas and implicated exocrine pancreas cells, not just immune cells, in disease risk.Nature, 2021 -
Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes riskMapped chromatin accessibility in thousands of individual islet cells to show which cell types and cell states carry type 2 diabetes genetic risk.Nature Genetics, 2021 - Understanding pancreatic mechanisms of diabetes risk with genetic association and single cell epigenome dataPhD Thesis, UC San Diego, 2021
2020
2019
2018
2015
Talks and presentations
- 2026Tirzepatide was associated with differential proteomic responses compared to semaglutide: exploratory findings from the SURMOUNT-5 trial
- 2025Advancing Early Target Discovery through Large-Scale Proteomics and Expansion Plans for the UKB-PPP
Press
- 2026
- 2023
- 2021